Skip to main content

Table 1 Associations of PGM1 expression with clinicopathological factors in CRC patients

From: PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway

Variable

Number

PGM1 expression

P-value

High

Low

(N = 38)

(N = 38)

Age(year)

 < 65

59 (77.6%)

31 (81.6%)

28 (73.7%)

0.582

 ≥ 65

17 (22.4%)

7 (18.4%)

10 (26.3%)

 

Gender

 Female

32 (42.1%)

12 (31.6%)

20 (52.6%)

0.104

 Male

44 (57.9%)

26 (68.4%)

18 (47.4%)

 

Tumor size (cm)

 < 5

41 (53.9%)

26 (68.4%)

15 (39.5%)

0.021

 ≥ 5

35 (46.1%)

12 (31.6%)

23 (60.5%)

 

Differentiation

 Moderate

19 (25.0%)

9 (23.7%)

10 (26.3%)

0.447

 Poor

34 (44.7%)

15 (39.5%)

19 (50.0%)

 

 Well

23 (30.3%)

14 (36.8%)

9 (23.7%)

 

Lymphatic node metastasis

 Negative

42 (55.3%)

28 (73.7%)

14 (36.8%)

0.003

 Positive

34 (44.7%)

10 (26.3%)

24 (63.2%)

 

TNM stage

 I + II

34 (44.7%)

25 (65.8%)

9 (23.7%)

 < 0.001

 III + IV

42 (55.3%)

13 (34.2%)

29 (76.3%)

 

Distant metastasis

 No

44 (57.9%)

27 (71.1%)

17 (44.7%)

0.037

 Yes

32 (42.1%)

11 (28.9%)

21 (55.3%)

 

1 years of survival

0.003

 Live

62 (81.6%)

36 (94.7%)

26 (68.4%)

 

 Dead

14 (18.4%)

2 (5.3%)

12 (31.6%)

 

5 years of survival

 < 0.001

 Live

29 (38.2%)

23 (60.5%)

6 (15.8%)

 

 Dead

47 (61.8%)

15 (39.5%)

32 (84.2%)

Â